Cargando…

Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation

Bone morphogenetic protein 2 (BMP-2) is a potent osteoinductive cytokine and a growing number of in vitro studies analyze its effects on human mesenchymal stem cells (hMSC) derived from aged or osteoporotic donors. In these studies the exact quantification of osteogenic differentiation capacity is o...

Descripción completa

Detalles Bibliográficos
Autores principales: Heggebö, Jostein, Haasters, Florian, Polzer, Hans, Schwarz, Christina, Saller, Maximilian Michael, Mutschler, Wolf, Schieker, Matthias, Prall, Wolf Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083304/
https://www.ncbi.nlm.nih.gov/pubmed/25002931
http://dx.doi.org/10.4081/or.2014.5242
_version_ 1782324357692915712
author Heggebö, Jostein
Haasters, Florian
Polzer, Hans
Schwarz, Christina
Saller, Maximilian Michael
Mutschler, Wolf
Schieker, Matthias
Prall, Wolf Christian
author_facet Heggebö, Jostein
Haasters, Florian
Polzer, Hans
Schwarz, Christina
Saller, Maximilian Michael
Mutschler, Wolf
Schieker, Matthias
Prall, Wolf Christian
author_sort Heggebö, Jostein
collection PubMed
description Bone morphogenetic protein 2 (BMP-2) is a potent osteoinductive cytokine and a growing number of in vitro studies analyze its effects on human mesenchymal stem cells (hMSC) derived from aged or osteoporotic donors. In these studies the exact quantification of osteogenic differentiation capacity is of fundamental interest. Nevertheless, the experimental conditions for osteogenic differentiation of aged hMSC have not been evaluated systematically and vary to a considerable extend. Aim of the study was to assess the influence of cell density, osteogenic differentiation media (ODM) change intervals and duration of BMP-2 stimulation on osteoinduction. Furthermore, time series were carried out for osteogenic differentiation and BMP-2 concentration in ODM/BMP-2 cell culture supernatants. The experiments were performed using hMSC isolated from femoral heads of aged patients undergoing hip joint replacement. ODM change intervals of 96 hours resulted in significantly higher calcium deposition compared to shorter intervals. A cell density of 80% prior to stimulation led to stronger osteoinduction compared to higher cell densities. In ODM, aged hMSC showed a significant induction of calcium deposition after 9 days. Added to ODM, BMP-2 showed a stable concentration in the cell culture supernatants for at least 96 hours. Addition of BMP-2 to ODM for the initial 4 days led to a significantly higher induction of osteogenic differentiation compared to ODM alone. On the other hand, addition of BMP-2 for 21 days almost abrogated the osteoinductive effect of ODM. We could demonstrate that the factors investigated have a substantial impact on the extent of osteogenic differentiation of aged hMSC. Consequently, it is of upmost importance to standardize the experimental conditions in order to enable comparability between different studies. We here define standard conditions for osteogenic differentiation in regard to the specific features of aged hMSC. The finding that BMP-2 induces or inhibits osteogenic differentiation in a time dependent manner indicates an age related alteration in signal transduction of hMSC and requires further investigation.
format Online
Article
Text
id pubmed-4083304
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-40833042014-07-07 Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation Heggebö, Jostein Haasters, Florian Polzer, Hans Schwarz, Christina Saller, Maximilian Michael Mutschler, Wolf Schieker, Matthias Prall, Wolf Christian Orthop Rev (Pavia) Article Bone morphogenetic protein 2 (BMP-2) is a potent osteoinductive cytokine and a growing number of in vitro studies analyze its effects on human mesenchymal stem cells (hMSC) derived from aged or osteoporotic donors. In these studies the exact quantification of osteogenic differentiation capacity is of fundamental interest. Nevertheless, the experimental conditions for osteogenic differentiation of aged hMSC have not been evaluated systematically and vary to a considerable extend. Aim of the study was to assess the influence of cell density, osteogenic differentiation media (ODM) change intervals and duration of BMP-2 stimulation on osteoinduction. Furthermore, time series were carried out for osteogenic differentiation and BMP-2 concentration in ODM/BMP-2 cell culture supernatants. The experiments were performed using hMSC isolated from femoral heads of aged patients undergoing hip joint replacement. ODM change intervals of 96 hours resulted in significantly higher calcium deposition compared to shorter intervals. A cell density of 80% prior to stimulation led to stronger osteoinduction compared to higher cell densities. In ODM, aged hMSC showed a significant induction of calcium deposition after 9 days. Added to ODM, BMP-2 showed a stable concentration in the cell culture supernatants for at least 96 hours. Addition of BMP-2 to ODM for the initial 4 days led to a significantly higher induction of osteogenic differentiation compared to ODM alone. On the other hand, addition of BMP-2 for 21 days almost abrogated the osteoinductive effect of ODM. We could demonstrate that the factors investigated have a substantial impact on the extent of osteogenic differentiation of aged hMSC. Consequently, it is of upmost importance to standardize the experimental conditions in order to enable comparability between different studies. We here define standard conditions for osteogenic differentiation in regard to the specific features of aged hMSC. The finding that BMP-2 induces or inhibits osteogenic differentiation in a time dependent manner indicates an age related alteration in signal transduction of hMSC and requires further investigation. PAGEPress Publications, Pavia, Italy 2014-06-03 /pmc/articles/PMC4083304/ /pubmed/25002931 http://dx.doi.org/10.4081/or.2014.5242 Text en ©Copyright J. Heggebö et al. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Heggebö, Jostein
Haasters, Florian
Polzer, Hans
Schwarz, Christina
Saller, Maximilian Michael
Mutschler, Wolf
Schieker, Matthias
Prall, Wolf Christian
Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation
title Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation
title_full Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation
title_fullStr Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation
title_full_unstemmed Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation
title_short Aged Human Mesenchymal Stem Cells: The Duration of Bone Morphogenetic Protein-2 Stimulation Determines Induction or Inhibition of Osteogenic Differentiation
title_sort aged human mesenchymal stem cells: the duration of bone morphogenetic protein-2 stimulation determines induction or inhibition of osteogenic differentiation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083304/
https://www.ncbi.nlm.nih.gov/pubmed/25002931
http://dx.doi.org/10.4081/or.2014.5242
work_keys_str_mv AT heggebojostein agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT haastersflorian agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT polzerhans agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT schwarzchristina agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT sallermaximilianmichael agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT mutschlerwolf agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT schiekermatthias agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation
AT prallwolfchristian agedhumanmesenchymalstemcellsthedurationofbonemorphogeneticprotein2stimulationdeterminesinductionorinhibitionofosteogenicdifferentiation